Uli Bialucha is Chief Scientific Officer for Xilio Therapeutics, Inc.

In the past he occupied the position of Vice President-Drug Discovery at Immunitas Therapeutics, Inc.

He received an undergraduate degree from the University of Sussex and a doctorate from University College London.